Loading...

Welcome to the Nanomedicines Symposium 2025

APS

The Academy of Pharmaceutical Sciences’ Nanomedicine focus group, in collaboration with the British Society of Nanomedicine, will be hosting a special one-day symposium themed “Nanomedicine innovations, applications and future trends”. The event will be held at Cardiff University on Monday 8th September 2025.

The symposium aims to bring together researchers of all career stages from academia and industry, as well as practitioners in the field of nanomedicine to share their latest research findings, network with peers, and engage with leading experts in the field. There will be oral presentations, poster sessions and networking events (with prizes).

DISCOUNTS are available for APS Members and the British Society of Nanomedicine Members

Programme

Presentations, networking, posters and dynamic debate.

Registration

See registration fees and get your tickets by clicking the link.

Abstract Submission

Find out more about requirements and submission by clicking the link below.

Accommodation & Travel

Click the link below to find hotel and airport details.

Sponsorship

Find out more on how to exhibit or sponsor by clicking the link.

Organising Committee

Professor Steve Conlan

Professor R. Steven Conlan PhD FRSB, Professor of Molecular and Cellular Biology, Reproductive Biology and Gynaecological Oncology, Programme Director Swansea University, Houston Methodist Academic Institute joint PhD scheme, Swansea University Medical School, UK

Steve Conlan FRSB is Professor of Molecular and Cell Biology, Swansea University Medical School, with over 25 years of experience in biomedical research and higher education.

Prof Conlan is involved in the leadership of several organisations; Chair of the Board of Trustees of the British Society of Nanomedicine, and Co-Vice Chair of the European Technology Platform – Nanomedicine. He is programme board member, and research and innovation group chair, for two national precision medicine initiatives; Advanced Therapies Wales and Genomics Partnerships Wales, and is a CReSt: cancer research strategy for Wales delivery group member.

His university research focuses on the development of advanced therapeutics; Antibody Drug Conjugates, exosomes, and nanoparticle deliver systems, and understanding disease processes using functional genomics.

Professor Elaine Ferguson

Professor Elaine Ferguson, Professor in Polymer Therapeutics, School of Dentistry, Cardiff University, UK

Elaine graduated from the University of Manchester with a Master of Pharmacy degree in 2003, before completing a PhD with Prof Ruth Duncan at Cardiff University’s Welsh School of Pharmacy in 2008, in which she developed a bioresponsive polymer-phospholipase conjugate for the treatment of breast cancer. This research initiated Elaine’s long-standing interest in using natural biodegradable polymers as novel carriers for bioactive agents. Having demonstrated the feasibility of bioresponsive polymer therapeutics in cancer, Elaine joined Cardiff University’s School of Dentistry, where her interests focused on exploring new clinical applications, including chronic wound healing, infection and spinal cord injury. Her ongoing research aims to optimise drug release by attachment of biodegradable polysaccharides to protein and peptide drugs, in order to direct them to sites of inflammation, thereby minimising toxicity, overcoming resistance and increasing bioavailability.

Arwyn T. Jones

Arwyn T. Jones, Professor of Membrane Traffic and Drug Delivery, School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Wales, UK

Arwyn obtained his PhD, under the supervision of Sir Tom Blundell, in protein crystallography at Birkbeck College, University of London. He then undertook postdoctoral research on endocytosis at the University of Liverpool, Harvard University and EMBL Heidelberg- as EMBO and Alexander von Humboldt fellow. Following a BBC Scholarship to gain a Diploma in Journalism at Bangor University he was appointed as lecturer at the Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University. There, he is now Professor of Membrane Traffic and Drug Delivery and Director for Research Innovation and Engagement

His research falls under themes of cancer cell biology, endocytosis and drug delivery, all of which aim to enhance our capacity to deliver small molecule drugs and biopharmaceuticals to defined regions of cells. He has published >100 papers and throughout his career he has collaborated with a long list of national and international academic groups, SMEs and major companies. He currently sits as Editorial Board member of J. Controlled Release and Membranes. Arwyn is also extremely proactive in public engagement with science, organising small and large science exhibitions locally in Cardiff and across Wales- see home page for details.

Speakers and Moderators

JONES, Robert

PARKER, Alan

PATEL, Asha

RAEMDONCK, Koen

Symposium Venue

Cardiff University has a long and proud history, dating back to 1883 when it was founded as the University College of Wales. Today, Cardiff University is a leading research institution, with a global reputation for excellence. The Meeting will be located in the Redwood Building that houses the School of Pharmacy and Pharmaceutical Sciences. It is located near heart of the city and very close to the Principality Stadium that one day later (9th-11th of September) will host the APS 16th International PharmSci Conference.

Our thanks to Cardiff University and the School of Pharmacy and Pharmaceutical Sciences for hosting this symposium.